Atlas FDA

IMMULITE 2000 XPI HBSAG

FDA premarket approval P010050 · decided 2002-07-26

Approval details

PMA number
P010050
Trade name
IMMULITE 2000 XPI HBSAG
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Siemens Healthcare Diagnostics Products, Ltd.
Date received
2001-08-31
Decision date
2002-07-26
Days to decision
329 days
Decision code
APRL
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Llanberis
Statement
APPROVAL FOR THE IMMULITE HBSAG, IMMULITE 2000 HBSAG AND IMMULITE HBSAG CONFIRMATORY KIT. THESE DEVICES ARE INDICATED FOR: IMMULITE HBSAG: IMMULITE HBSAG IS A SOLID-PHASED CHEMILUMINESCENT ENZYME IMMUNOASSAY DESIGNED FOR IN VITRO USE WITH THE IMMULITE AUTOMATED IMMUNOASSAY ANALYZER FOR THE QUALITATIVE DETECTION OF HEPATITIS B SURFACE ANTIGEN (HBSAG) IN HUMAN SERUM OR PLASMA (EDTA, HEPARINIZED, CITRATE). IT IS INTENDED FOR IN VITRO DIAGNOSTIC USE FOR THE LABORATORY DIAGNOSIS OF ACUTE AND CHRONIC

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
IMMULITE® 2000 BR-MA (K233946)Siemens Healthcare Diagnostics Products, Ltd.2024-03-13
IMMULITE/IMMULITE 1000 OM-MA, IMMULITE 2000 OM-MA (K213510)Siemens Healthcare Diagnostics Products, Ltd.2023-09-08
IMMULITE® 2000 Cortisol (K202826)Siemens Healthcare Diagnostics Products, Ltd.2021-01-15
IMMULITE/IMMULITE® 1000 Cortisol (K203270)Siemens Healthcare Diagnostics Products, Ltd.2021-01-15